We proposed cdkn1a as an early-signaling indicator of the preosteoporosis state, against which therapies could be designed, thereby improving our understanding of the molecular pathogenesis of osteoporosis onset for early diagnosis and even mitigation. Here, CDKN1A is linked to osteoporosis.